Where Do Drug Companies Values Lie?
The FDA approved a new medication, an inhaled insulin
product called Exubera. There was a marketing
agreement by 2 drugs companies, Nektar and Pfizer
for the product.
The product was on the market for 6 months and it
was not selling. The warning label linked the use of
the drug with lung cancer. It seems the general
public didn’t think the risk of lung cancer was worth
the “convenience” of using an inhaler.
Pfizer pulled out of the agreement to market the
product. You would think no one would be part of
a drug that was linked to causing cancer, but these
were drug companies who run things differently. A
cancer link would be a good reason to want out of
the agreement but that isn’t the reason Pfizer wanted
out. The product wasn’t on track to make
enough money.
The big question should be why did the FDA allow this
product to be placed on the market? Of course the
FDA did require the warning label placed on the
product packaging. This is sufficient proof of how the
FDA is monitoring the safety of drugs for the market
place. I wonder who is monitoring the people at the
FDA? Better question is why do people at the FDA
think the risk of lung cancer is
not a public health danger?
Then think twice about a product that has been FDA
approved when a doctor tells you “the drug is safe,
it is FDA approved”. You know the government
department, FDA that was given the power to monitor
market place products to protect the public’s health.
READ IT AGAIN if you have any doubts about where
the drug companies values are.
Leave a comment on this article. There will be coming soon.
Tags: Drug advertisement, drug companies advertisements, drug companies profits, health, health care